longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Co-Diagnostics

CODX

1.1200.00% ( 0.000 )
Closed: Sep 9, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.17, within the reasonable range, cheaper than 34.23% of the time in the past 5 years, and the industry ranks 57/175, the industry Median -0.96.

-0.166xP/E
$1.12Stock price
$-6.74Earnings per share
-0.166xP/E
Stock price$1.12Earnings per share$-6.74

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.39x
Typical range
-1.04x–4.49x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.86x141.71%$12.61B
GKOSUSGlaukos
-56.39x75.34%$10.60B
TFXUSTeleflex
-5.57x118.39%$5.75B
IRTCUSIRhythm
-282.60x71.96%$3.94B
PLSEUSPulse Biosciences
-47.19x27.55%$3.78B
AXGNUSAxogen
-75.75x23.53%$2.54B
BFLYUSButterfly Network
-26.54x34.41%$1.99B
ASSTUSStrive
-1.89x63.26%$1.85B
NVCRUSNovocure
-12.25x2.52%$1.82B
KMTSUSKestra Medical Tech
-10.72x5.19%$1.41B
ATECUSAlphatec
-12.62x41.67%$1.39B
TNDMUSTandem Diabetes
-21.00x77.82%$1.33B
DRTSUSAlpha Tau Medical
-14.23x--$1.32B
IARTUSIntegra LifeSciences
-174.63x109.50%$1.26B
AORTUSArtivion
-385.34x266.67%$1.23B
PRCTUSPROCEPT BioRobotics
-10.82x3.47%$1.19B
ENOVUSEnovis
-1.00x100.97%$1.10B
CBLLUSCeribell
-14.19x35.15%$936.81M
QDELUSQuidelOrtho
-0.83x75.33%$866.79M
AVRUSAnteris Tech Global
-8.03x53.33%$831.32M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.